Martin Baatz

Bio-Ai Health, Inc. is an American company that is dedicated to advancing precision medicine through the use of their AI technology. The company's goal is to improve disease diagnosis and predict patient response to therapy. The company was founded by Thomas Colarusso and Alan Jerusalmi, with Thomas Colarusso serving as the CEO since incorporation.

Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany.